Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

334 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Modeling complement activation on human glomerular microvascular endothelial cells.
Stevens KH, Baas LM, van der Velden TJAM, Bouwmeester RN, van Dillen N, Dorresteijn EM, van Zuilen AD, Wetzels JFM, Michels MAHM, van de Kar NCAJ, van den Heuvel LP. Stevens KH, et al. Among authors: wetzels jfm. Front Immunol. 2023 Oct 25;14:1206409. doi: 10.3389/fimmu.2023.1206409. eCollection 2023. Front Immunol. 2023. PMID: 37954621 Free PMC article.
COVID-19 vaccination and Atypical hemolytic uremic syndrome.
Bouwmeester RN, Bormans EMG, Duineveld C, van Zuilen AD, van de Logt AE, Wetzels JFM, van de Kar NCAJ. Bouwmeester RN, et al. Among authors: wetzels jfm. Front Immunol. 2022 Dec 1;13:1056153. doi: 10.3389/fimmu.2022.1056153. eCollection 2022. Front Immunol. 2022. PMID: 36531998 Free PMC article.
Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective: Results of the CUREiHUS Study.
Bouwmeester RN, Duineveld C, Wijnsma KL, Bemelman FJ, van der Heijden JW, van Wijk JAE, Bouts AHM, van de Wetering J, Dorresteijn E, Berger SP, Gracchi V, van Zuilen AD, Keijzer-Veen MG, de Vries APJ, van Rooij RWG, Engels FAPT, Altena W, de Wildt R, van Kempen E, Adang EM, Ter Avest M, Ter Heine R, Volokhina EB, van den Heuvel LPWJ, Wetzels JFM, van de Kar NCAJ. Bouwmeester RN, et al. Among authors: wetzels jfm. Kidney Int Rep. 2022 Oct 18;8(1):91-102. doi: 10.1016/j.ekir.2022.10.013. eCollection 2023 Jan. Kidney Int Rep. 2022. PMID: 36644349 Free PMC article.
Proteinuria and Exposure to Eculizumab in Atypical Hemolytic Uremic Syndrome.
Ter Avest M, Steenbreker H, Bouwmeester RN, Duineveld C, Wijnsma KL, van den Heuvel LPWJ, Langemeijer SMC, Wetzels JFM, van de Kar NCAJ, Ter Heine R; CUREiHUS Study Group. Ter Avest M, et al. Among authors: wetzels jfm. Clin J Am Soc Nephrol. 2023 Jun 1;18(6):759-766. doi: 10.2215/CJN.0000000000000145. Epub 2023 Apr 10. Clin J Am Soc Nephrol. 2023. PMID: 36913245
Eculizumab Rescue Therapy in Patients With Recurrent Atypical Hemolytic Uremic Syndrome After Kidney Transplantation.
Duineveld C, Bouwmeester RN, Wijnsma KL, Bemelman FJ, van der Heijden JW, Berger SP, van den Heuvel LPWJ, van de Kar NCAJ, Wetzels JFM; Dutch aHUS Working Group. Duineveld C, et al. Among authors: wetzels jfm. Kidney Int Rep. 2023 Jan 19;8(4):715-726. doi: 10.1016/j.ekir.2023.01.016. eCollection 2023 Apr. Kidney Int Rep. 2023. PMID: 37069997 Free PMC article.
Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis.
Writing Group for the CKD Prognosis Consortium; Grams ME, Coresh J, Matsushita K, Ballew SH, Sang Y, Surapaneni A, Alencar de Pinho N, Anderson A, Appel LJ, Ärnlöv J, Azizi F, Bansal N, Bell S, Bilo HJG, Brunskill NJ, Carrero JJ, Chadban S, Chalmers J, Chen J, Ciemins E, Cirillo M, Ebert N, Evans M, Ferreiro A, Fu EL, Fukagawa M, Green JA, Gutierrez OM, Herrington WG, Hwang SJ, Inker LA, Iseki K, Jafar T, Jassal SK, Jha V, Kadota A, Katz R, Köttgen A, Konta T, Kronenberg F, Lee BJ, Lees J, Levin A, Looker HC, Major R, Melzer Cohen C, Mieno M, Miyazaki M, Moranne O, Muraki I, Naimark D, Nitsch D, Oh W, Pena M, Purnell TS, Sabanayagam C, Satoh M, Sawhney S, Schaeffner E, Schöttker B, Shen JI, Shlipak MG, Sinha S, Stengel B, Sumida K, Tonelli M, Valdivielso JM, van Zuilen AD, Visseren FLJ, Wang AY, Wen CP, Wheeler DC, Yatsuya H, Yamagata K, Yang JW, Young A, Zhang H, Zhang L, Levey AS, Gansevoort RT. Writing Group for the CKD Prognosis Consortium, et al. JAMA. 2023 Oct 3;330(13):1266-1277. doi: 10.1001/jama.2023.17002. JAMA. 2023. PMID: 37787795 Free PMC article.
A Caution Against the Use of C5b-9 Endothelial Assay to Support Eculizumab Therapy: A response to Maritati et al.: "Eculizumab first" in the management of posttransplant thrombotic microangiopathy.
Duineveld C, van de Kar NCAJ, Wetzels JFM. Duineveld C, et al. Among authors: wetzels jfm. Kidney Int Rep. 2024 Mar 1;9(5):1538. doi: 10.1016/j.ekir.2024.02.1434. eCollection 2024 May. Kidney Int Rep. 2024. PMID: 38707808 Free PMC article. No abstract available.
Age and association of kidney measures with mortality and end-stage renal disease.
Hallan SI, Matsushita K, Sang Y, Mahmoodi BK, Black C, Ishani A, Kleefstra N, Naimark D, Roderick P, Tonelli M, Wetzels JF, Astor BC, Gansevoort RT, Levin A, Wen CP, Coresh J; Chronic Kidney Disease Prognosis Consortium. Hallan SI, et al. JAMA. 2012 Dec 12;308(22):2349-60. doi: 10.1001/jama.2012.16817. JAMA. 2012. PMID: 23111824 Free PMC article.
334 results